FDA approves combination therapy for blurry vision
The FDA has approved Yuvezzi (carbachol and brimonidine tartrate), a once-daily eye drop to treat presbyopia in adults. Presbyopia is...
Vision
Lyell to Highlight Vision for its Next-Generation CAR
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025...
